Celldex Therapeutics (CLDX)
(Delayed Data from NSDQ)
$34.78 USD
-2.77 (-7.38%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $34.75 -0.03 (-0.09%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Earnings News For CLDX
-
Celldex: Q1 Earnings Snapshot
-
Celldex Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
Celldex: Q4 Earnings Snapshot
-
Celldex Therapeutics (CLDX) Reports Q4 Loss, Tops Revenue Estimates
-
Celldex Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
-
Celldex: Q3 Earnings Snapshot
-
Celldex Reports Third Quarter 2023 Financial Results and Provides Corporate Update
-
Celldex Therapeutics (CLDX) Reports Q2 Loss, Misses Revenue Estimates
-
Celldex: Q2 Earnings Snapshot
-
Celldex Reports Second Quarter 2023 Financial Results and Provides Corporate Update
-
Celldex Therapeutics (CLDX) Reports Q1 Loss, Tops Revenue Estimates
-
Celldex: Q1 Earnings Snapshot
-
Celldex Reports First Quarter 2023 Financial Results and Provides Corporate Update
-
Celldex: Q4 Earnings Snapshot
-
Celldex Reports Fourth Quarter and Year End 2022 Financial Results and Provides Corporate Update
-
Celldex Therapeutics (CLDX) Reports Q3 Loss, Tops Revenue Estimates
-
Celldex: Q3 Earnings Snapshot
-
Celldex Reports Third Quarter 2022 Financial Results and Provides Corporate Update
-
Earnings Preview: Celldex Therapeutics (CLDX) Q3 Earnings Expected to Decline
-
Celldex Therapeutics (CLDX) Reports Q2 Loss, Lags Revenue Estimates
-
Celldex Therapeutics (CLDX) Reports Q1 Loss, Misses Revenue Estimates
-
Celldex Therapeutics (CLDX) Reports Q3 Loss, Lags Revenue Estimates
-
Celldex Therapeutics (CLDX) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
-
Celldex Therapeutics (CLDX) Reports Q2 Loss, Tops Revenue Estimates
-
Will Celldex Therapeutics (CLDX) Report Negative Q2 Earnings? What You Should Know